What is a stock summary page? Click here for an overview.
Business Description
Anterogen Co Ltd
ISIN : KR7065660003
Compare
Compare
Traded in other countries / regions
065660.Korea Index Membership
KOSDAQ Composite Index IPO Date
2016-02-15Description
Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 19.92 | |||||
| Beneish M-Score | -2.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.6 | |||||
| 3-Year EPS without NRI Growth Rate | -3.2 | |||||
| 3-Year FCF Growth Rate | 44 | |||||
| 3-Year Book Growth Rate | -3 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.26 | |||||
| 9-Day RSI | 53.64 | |||||
| 14-Day RSI | 53.51 | |||||
| 3-1 Month Momentum % | -3.06 | |||||
| 6-1 Month Momentum % | 22.82 | |||||
| 12-1 Month Momentum % | 26.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 30.42 | |||||
| Quick Ratio | 29.69 | |||||
| Cash Ratio | 26.76 | |||||
| Days Inventory | 112.64 | |||||
| Days Sales Outstanding | 127.87 | |||||
| Days Payable | 70.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.1 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.91 | |||||
| Operating Margin % | -54.09 | |||||
| Net Margin % | -33.09 | |||||
| FCF Margin % | -16.9 | |||||
| ROE % | -1.97 | |||||
| ROA % | -1.85 | |||||
| ROIC % | -4.58 | |||||
| 3-Year ROIIC % | 12.25 | |||||
| ROC (Joel Greenblatt) % | -11.11 | |||||
| ROCE % | -2.38 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 26.71 | |||||
| PB Ratio | 1.69 | |||||
| Price-to-Tangible-Book | 1.82 | |||||
| EV-to-EBIT | -53.52 | |||||
| EV-to-EBITDA | -67.19 | |||||
| EV-to-Revenue | 22.22 | |||||
| EV-to-FCF | -128.86 | |||||
| Price-to-GF-Value | 1.18 | |||||
| Price-to-Projected-FCF | 6.31 | |||||
| Price-to-Net-Current-Asset-Value | 4.83 | |||||
| Price-to-Net-Cash | 5.6 | |||||
| Earnings Yield (Greenblatt) % | -1.88 | |||||
| FCF Yield % | -0.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anterogen Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 6,932.864 | ||
| EPS (TTM) (â‚©) | -237 | ||
| Beta | 0.62 | ||
| 3-Year Sharpe Ratio | -0.02 | ||
| 3-Year Sortino Ratio | -0.03 | ||
| Volatility % | 34.16 | ||
| 14-Day RSI | 53.51 | ||
| 14-Day ATR (â‚©) | 979.366229 | ||
| 20-Day SMA (â‚©) | 18707.5 | ||
| 12-1 Month Momentum % | 26.08 | ||
| 52-Week Range (â‚©) | 13100 - 23500 | ||
| Shares Outstanding (Mil) | 10.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anterogen Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anterogen Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anterogen Co Ltd Frequently Asked Questions
What is Anterogen Co Ltd(XKRX:065660)'s stock price today?
The current price of XKRX:065660 is â‚©19450.00. The 52 week high of XKRX:065660 is â‚©23500.00 and 52 week low is â‚©13100.00.
When is next earnings date of Anterogen Co Ltd(XKRX:065660)?
The next earnings date of Anterogen Co Ltd(XKRX:065660) is .
Does Anterogen Co Ltd(XKRX:065660) pay dividends? If so, how much?
Anterogen Co Ltd(XKRX:065660) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers